Abbott Laboratories
ABT
#66
Rank
NZ$344.21 B
Marketcap
$198.46
Share price
-0.03%
Change (1 day)
17.12%
Change (1 year)
Categories

Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.

Revenue for Abbott Laboratories (ABT)

Revenue in 2024 (TTM): NZ$66.67 Billion

According to Abbott Laboratories's latest financial reports the company's current revenue (TTM ) is NZ$70.04 Billion. In 2023 the company made a revenue of NZ$63.42 Billion a decrease over the revenue in the year 2022 that were of NZ$68.75 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Abbott Laboratories from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) NZ$66.67 B5.13%
2023 NZ$63.42 B-7.76%
2022 NZ$68.75 B9.03%
2021 NZ$63.06 B31.48%
2020 NZ$47.96 B1.25%
2019 NZ$47.37 B3.92%
2018 NZ$45.58 B18.2%
2017 NZ$38.56 B28.11%
2016 NZ$30.10 B0.98%
2015 NZ$29.81 B15.75%
2014 NZ$25.75 B-0.65%
2013 NZ$25.92 B-20.12%
2012 NZ$32.45 B-34.8%
2011 NZ$49.78 B9.21%
2010 NZ$45.58 B7.62%
2009 NZ$42.35 B-16.75%
2008 NZ$50.88 B50.4%
2007 NZ$33.83 B8.96%
2006 NZ$31.04 B-5%
2005 NZ$32.68 B18.5%
2004 NZ$27.58 B-3.01%
2003 NZ$28.43 B-15.85%
2002 NZ$33.79 B-13.84%
2001 NZ$39.21 B26.43%
2000 NZ$31.01 B22.58%
1999 NZ$25.30 B6.88%
1998 NZ$23.67 B15.62%
1997 NZ$20.47 B31.37%
1996 NZ$15.58 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NZ$149.03 B 112.77%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$102.15 B 45.84%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$72.00 B 2.80%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$6.77 B-90.33%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$55.36 B-20.96%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
NZ$80.61 B 15.09%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$27.03 B-61.40%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$87.02 B 24.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$84.87 B 21.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$68.40 B-2.34%๐Ÿ‡ฌ๐Ÿ‡ง UK